Over a week ago |
Upgrade
|
Evercore ISI analyst… Evercore ISI analyst Warren Cheng upgraded Foot Locker (FL) to Outperform from In Line with a price target of $60, up from $32. After Mary Dillon first joined in October, the firm was "intrigued with her self-awareness of the existential challenges Foot Locker faces" and at yesterday's investor day the firm thought she and her team articulated a "thoughtful, credible vision," the analyst tells investors. That vision "leans into the things that Nike, adidas and Under Armour can't do themselves as monobrands" and deepens Foot Locker's unique moats as a retailer, the firm contends. ShowHide Related Items >><< - 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- $121.14 /
+0.7598 (+0.63%) - 02/22/23
- Tiffany says Nike/Tiffany Air Force 1 1837 list opening March 3
- 02/13/23
- Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
- 02/02/23
- Tiffany teams with Nike on Air Force 1, set for release in March
- 01/24/23
- Nike trading resumes
- 03/20/23
- Foot Locker focusing on banners, geographies that will drive growth, says CEO
- 03/20/23
- Foot Locker to close stores, ecommerce in Hong Kong, Macau
- 11/29/22
- Foot Locker announces leadership team appointments
- 11/18/22
- Foot Locker rises 14.7%
- 03/08/23
- Adidas extends appointment of CFO Harm Ohlmeyer by three years
- 03/08/23
- Adidas to slash dividend to EUR 0.70, down from EUR 3.30 last year
- 11/09/22
- Adidas sees 'strong' bottomline improvement in 2023
- 11/09/22
- Adidas sees FY22 currency-neutral revenue up at a low single digit rate
- 03/21/23 TD Cowen
- Foot Locker price target raised to $43 from $39 at TD Cowen
- 03/21/23 BofA
- Foot Locker price target lowered to $45 from $48 at BofA
- 03/21/23 BTIG
- Foot Locker price target lowered to $53 from $55 at BTIG
- $121.14 /
+0.7598 (+0.63%) - 03/21/23 Citi
- Foot Locker upgraded to Buy from Neutral at Citi
- 03/17/23 Jefferies
- Jefferies expects Nike Q3 to beat based on positive digital data trends
- 03/16/23 Redburn
- Nike initiated with a Sell at Redburn
- 03/14/23 Barclays
- Nike price target raised to $110 from $109 at Barclays
- 03/17/23 RBC Capital
- Adidas price target raised to EUR 130 from EUR 110 at RBC Capital
- 03/13/23 Morgan Stanley
- Nike price target raised to $140 at Morgan Stanley ahead of Q3 report
- 03/01/23 HSBC
- Adidas upgraded to Buy from Hold at HSBC
- 03/16/23 Williams Trading
- Under Armour upgraded to Buy from Hold at Williams Trading
- 03/16/23 Redburn
- Under Armour initiated with a Buy at Redburn
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- $121.14 /
+0.7598 (+0.63%) - 12/20/22
- Nike sees FY23 revenue growth in mid teens, consensus $49.01B
- 12/20/22
- Nike reports Q2 EPS 85c, consensus 65c
- 12/20/22
- Notable companies reporting after market close
- 09/29/22
- Nike reports Q1 EPS 93c, consensus 92c
- 03/20/23
- Foot Locker targeting adjusted EPS growth in low to mid 20% range for FY24-FY26
- 03/20/23
- Foot Locker sees FY23 adjusted EPS $3.35-$3.65, consensus $4.48
- 03/20/23
- Foot Locker reports Q4 adjusted EPS 97c, consensus 51c
- 11/18/22
- Foot Locker raises FY22 EPS view to $4.42-$4.50 from $4.25-$4.45
- 03/08/23
- Adidas: 2023 to be 'transition year,' sees revenue down at HSD rate
- 03/08/23
- Adidas reports currency-neutral revenues up 1% in 2022
- 02/09/23
- Adidas reports preliminary 2022 sales up 1% in currency-neutral terms
- 02/09/23
- Adidas sees 2023 currency-neutral sales down high-single-digits
- $121.14 /
+0.7598 (+0.63%) - 12/05/22
- Nike cut ties with Kyrie Irving, The Athletic reports
- 11/25/22
- Brookfield acquired Nike label supplier Trimco Group, Bloomberg reports
- 11/15/22
- Nike to open online store for virtual sneakers, Bloomberg reports
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 10/26/22
- Foot Locker to remove Yeezy products from stores, CNBC reports
- 11/28/22
- Adidas investigating Ye conduct claims, CNBC reports
- 11/27/22
- Adidas discussed risk of staff direct exposure to Kanye West years ago, WSJ says
- 11/26/22
- Adidas, Puma stand to gain as German consumers boost economy, Barron's says
- 11/25/22
- Adidas to probe alleged misconduct by Kanye West, WSJ reports
- 03/13/23
- What You Missed On Wall Street On Monday
- 03/13/23
- What You Missed On Wall Street This Morning
- 03/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $121.14 /
+0.7598 (+0.63%) - 03/16/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/11/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/07/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/20/23
- What You Missed On Wall Street On Monday
- 03/20/23
- What You Missed On Wall Street This Morning
- 03/20/23
- Fly Intel: Pre-market Movers
- 03/18/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/09/23
- What You Missed On Wall Street On Thursday
- 01/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/28/22
- What You Missed On Wall Street This Morning
- 10/25/22
- What You Missed On Wall Street On Tuesday
- 10/31/22
- Under Armour Class A call volume above normal and directionally bullish
- 10/10/22
- Under Armour Class A call volume above normal and directionally bullish
- $121.14 /
+0.7598 (+0.63%) - 12/22/22
- Unusually active option classes on open December 22nd
- 12/21/22
- Early notable gainers among liquid option names on December 21st
- 12/21/22
- Notable open interest changes for December 21st
- 12/20/22
- Nike options imply 7.5% move in share price post-earnings
- 03/13/23
- Foot Locker put volume heavy and directionally bearish
- 03/13/23
- Unusually active option classes on open March 13th
- 01/23/23
- Foot Locker call volume above normal and directionally bullish
- 12/21/22
- Unusually active option classes on open December 21st
|
On The Fly
|
Want to get stock-moving… ShowHide Related Items >><< - 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 02/06/23
- Skyworks announces new $2B buyback
- 01/31/23
- Mobile phone, PC shipments to fall another 4.4% in 2023, Gartner says
- 01/05/23
- Skyworks says inventory overhang could possibly last into June
- 09/21/22
- Skyworks CEO: Our portfolio is expanding
- 03/15/23
- Cathie Wood's ARK Investment bought 122.6K shares of Block today
- 03/14/23
- Cathie Wood's ARK Investment bought 186.3K shares of Block today
- 03/13/23
- Cathie Wood's ARK Investment bought 119.4K shares of Block today
- 03/01/23
- Square provides policy and pricing updates
- 03/14/23
- Arrow Electronics, Qualcomm expand their collaboration
- 03/08/23
- Qualcomm increases dividend 7% to 80c
- 02/28/23
- Nokia, Qualcomm, T-Mobile achieve 5G Carrier Aggregation
- 02/15/23
- Qualcomm unveils Snapdragon X75 5G modem-RF to optimize 5G potential
- 02/22/23
- Tiffany says Nike/Tiffany Air Force 1 1837 list opening March 3
- 02/13/23
- Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
- 02/02/23
- Tiffany teams with Nike on Air Force 1, set for release in March
- 01/24/23
- Nike trading resumes
- 02/23/23
- Mytheresa falls -12.9%
- 02/23/23
- Mytheresa falls -14.1%
- 01/12/23
- lululemon teams with Nedap to advance RFID technology across stores
- 01/09/23
- Lululemon falls 14% to $282.02 after revising Q4 guidance
- 12/08/22
- Lululemon falls 9% to $340.75 after Q3 results and guidance
- 12/08/22
- Lululemon reports Q3 SSS up 22% or 25% on constant FX basis
- 12/27/22
- LivePerson names three new directors as part of prior deal with Starboard
- 10/04/22
- LivePerson appoints Zive as Chief Marketing Officer
- 03/03/23
- Samsara rises 21.2%
- 03/03/23
- Samsara rises 13.3%
- 03/02/23
- Samsara says Q1 will be lowest quarter of the year on net new ARR
- 12/02/22
- Samsara rises 21.9%
- 02/23/23
- Intuit names Sandeep Singh Aujla as new CFO
- 02/08/23
- Asure teams with Intuit's TurboTax to aid small businesses with taxes, hiring
- 01/05/23
- Nordstrom appoints Atticus Tysen to Board of Directors
- 12/06/22
- AvidXchange announces invoice-to-pay API integration with Intuit QuickBooks
- 03/06/23
- Intel delaying Falcon Shores to 2025, McVeigh says in blog post
- 02/22/23
- Intel provides update on effort to optimize cost structure
- 02/22/23
- Intel reduces quarterly dividend to 12.5c per share
- 02/15/23
- HP announces Z by HP workstation desktop lineup
- 03/15/23
- Halozyme provides update on EPO decision regarding Darzalex
- 03/01/23
- Halozyme director Henderson sells 20,000 common shares
- 01/10/23
- Halozyme falls 7% to $52.00 after below-consensus FY23 guidance
- 01/10/23
- Halozyme announces anticipated key events in 2023
- 10/17/22
- Fluent data now available in TransUnion's TruAudience data marketplace
- 10/11/22
- Fluent appoints David Graff and Richard Pfenniger as directors
- 10/05/22
- Fluent launches Purpose mobile app
- 12/23/22
- FedEx warns potential delays possible for packages due Dec. 23 and 24
- 12/20/22
- FedEx says drop in volume accelerated through Q2
- 12/20/22
- FedEx remains confident in high capture rate
- 12/20/22
- FedEx says Ground service now back to pre-pandemic levels
- 03/15/23
- Esperion reports disagreement with Daiichi Sankyo over milestone payments
- 03/08/23
- Esperion says ILEP recommends use of bempedoic acid ahead of PCSK9 inhibitors
- 03/05/23
- Esperion announced full results from landmark CLEAR outcomes study
- 01/11/23
- RFK Racing enters team-wide partnership with Esperion
- 02/27/23
- Cathie Wood's ARK Investment bought 115K shares of AMD today
- 02/22/23
- AMD expands support of 5G partner ecosystem
- 02/21/23
- Cathie Wood's ARK Investment bought 72.8K shares of AMD today
- 02/14/23
- Lone Pine exited PayPal, initiated AMD position during Q4
- 03/14/23
- Apple launches Shop with a Specialist over Video
- 03/09/23
- Apple says Apple Music Classical releases March 28
- 03/08/23
- Apple backs new music startup Gamma
- 03/07/23
- Sonos to add support for spatial audio on Apple Music
- 03/16/23 Piper Sandler
- Piper starts Samsara at Neutral with valuation not compelling
- 03/15/23 Piper Sandler
- Samsara initiated with a Neutral at Piper Sandler
- 03/03/23 Goldman Sachs
- Samsara upgraded to Buy at Goldman ahead of free cash flow inflection
- 03/03/23 Goldman Sachs
- Samsara upgraded to Buy from Neutral at Goldman Sachs
- 03/15/23 UBS
- Intuit initiated with a Neutral at UBS
- 03/15/23 Daiwa
- Intuit initiated with an Outperform at Daiwa
- 02/27/23 Citi
- Intuit price target raised to $475 from $457 at Citi
- 02/24/23 BMO Capital
- Intuit price target raised to $462 from $448 at BMO Capital
- 03/16/23 Williams Trading
- Under Armour upgraded to Buy from Hold at Williams Trading
- 03/16/23 Redburn
- Under Armour initiated with a Buy at Redburn
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 03/16/23 Redburn
- Lululemon initiated with a Sell at Redburn
- 03/07/23 Jefferies
- Lululemon web and search trends point to possible slowdown, says Jefferies
- 03/06/23 Baird
- Lululemon price target lowered to $410 from $435 at Baird
- 02/22/23 Jefferies
- Data indicates Lululemon promo activity accelerated in January, says Jefferies
- 03/16/23 Redburn
- Nike initiated with a Sell at Redburn
- 03/14/23 Barclays
- Nike price target raised to $110 from $109 at Barclays
- 03/13/23 Morgan Stanley
- Nike price target raised to $140 at Morgan Stanley ahead of Q3 report
- 03/10/23 OTR Global
- Nike upgraded to Positive from Mixed view at OTR Global
- 03/16/23 TD Cowen
- TD Cowen downgrades Mytheresa on more cautious aspirational shoppers
- 03/16/23 TD Cowen
- Mytheresa downgraded to Market Perform from Outperform at TD Cowen
- 10/25/22 Morgan Stanley
- Farfetch price target lowered to $26 from $32 at Morgan Stanley
- 09/20/22 UBS
- Mytheresa price target raised to $16 from $14 at UBS
- 03/16/23 SVB Securities
- SVB Securities downgrades Halozyme to Market Perform given growth uncertainty
- 03/16/23 SVB Securities
- Halozyme downgraded to Market Perform from Outperform at SVB Securities
- 03/16/23 Wells Fargo
- Halozyme price target lowered to $55 from $65 at Wells Fargo
- 12/21/22 Morgan Stanley
- Halozyme assumed with an Overweight at Morgan Stanley
- 03/16/23 Barrington
- Fluent downgraded to Market Perform from Outperform at Barrington
- 03/16/23 Canaccord
- Fluent price target lowered to $3.50 from $4 at Canaccord
- 11/08/22 Canaccord
- Fluent price target lowered to $4 from $5 at Canaccord
- 05/10/22 Barrington
- Fluent upgraded to Outperform from Market Perform at Barrington
- 03/16/23 Northland
- Esperion downgraded to Underperform at Northland amid milestone uncertainty
- 03/16/23 Northland
- Esperion downgraded to Underperform from Market Perform at Northland
- 03/16/23 Needham
- Esperion price target lowered to $12 from $16 at Needham
- 03/16/23 BofA
- Esperion downgraded to Underperform at BofA after milestone dispute
- 03/16/23 Mizuho
- LivePerson price target lowered to $7 from $12 at Mizuho
- 03/16/23 Craig-Hallum
- Craig-Hallum says 'got LivePerson wrong,' downgrades to Hold
- 03/16/23 Evercore ISI
- LivePerson price target lowered to $6 from $12 at Evercore ISI
- 03/16/23 Craig-Hallum
- LivePerson downgraded to Hold from Buy at Craig-Hallum
- 03/15/23 Stifel
- FedEx upgraded to Buy from Hold at Stifel
- 03/13/23 BMO Capital
- FedEx price target raised to $210 from $180 at BMO Capital
- 03/10/23 Wells Fargo
- FedEx price target raised to $225 from $185 at Wells Fargo
- 03/09/23 Citi
- FedEx price target raised to $250 from $240 at Citi
- 03/16/23 Susquehanna
- Qualcomm upgraded at Susquehanna with China opening, Apple 'de-risked'
- 03/14/23 Evercore ISI
- Apple premium to big tech 'justified,' could expand further, says Evercore ISI
- 03/10/23 LightShed Partners
- Apple cut to Sell at LightShed on more conservative outlook for iPhone sales
- 03/10/23 LightShed Partners
- Apple downgraded to Sell from Neutral at LightShed Partners
- 03/16/23 Susquehanna
- Susquehanna upgrades 'RF integration master' Skyworks to Positive
- 03/16/23 Susquehanna
- Skyworks upgraded to Positive from Neutral at Susquehanna
- 03/01/23 Raymond James
- Skyworks assumed with a Market Perform at Raymond James
- 02/07/23 Wells Fargo
- Skyworks price target raised to $110 from $90 at Wells Fargo
- 03/16/23 Truist
- Black Knight price target lowered to $63 from $67 at Truist
- 03/16/23 Mizuho
- Mizuho upgrades Block to Buy on 'pivot to profitability'
- 03/16/23 Mizuho
- Block upgraded to Buy from Neutral at Mizuho
- 03/01/23 Baird
- Baird 'wouldn't be surprised' if price hikes add $60M to Square gross profit
- 03/16/23 Susquehanna
- Qualcomm upgraded to Positive from Neutral at Susquehanna
- 03/03/23 OTR Global
- Qualcomm displacing Broadcom for S23 components, says OTR Global
- 03/01/23 Raymond James
- Qualcomm resumed with a Market Perform at Raymond James
- 03/02/23 Credit Suisse
- Street revenue estimates need to come down for Micron, says Credit Suisse
- 03/01/23 Raymond James
- Raymond James resumes 'underappreciated AI/ML play' AMD with a Strong Buy
- 03/01/23 Raymond James
- AMD assumed with a Strong Buy at Raymond James
- 02/14/23 Benchmark
- AMD price target raised to $103 from $93 at Benchmark
- 03/16/23 Susquehanna
- Intel upgraded to Neutral at Susquehanna as headwinds ease
- 03/16/23 Susquehanna
- Intel upgraded to Neutral from Negative at Susquehanna
- 03/01/23 Raymond James
- Intel resumed with an Outperform at Raymond James
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 02/06/23
- Skyworks sees Q2 adjusted EPS $2.02, consensus $2.24
- 02/06/23
- Skyworks reports Q1 adjusted EPS $2.59, consensus $2.61
- 02/06/23
- Notable companies reporting after market close
- 11/03/22
- Skyworks sees Q1 revenue $1.3B-$1.35B, consensus $1.5B
- 02/23/23
- Block reports Q4 EPS 22c, consensus 30c
- 11/03/22
- Block reports Q3 adjusted EPS 42c, consensus 23c
- 11/03/22
- Notable companies reporting after market close
- 02/02/23
- Qualcomm sees Q2 adjusted EPS $2.05-$2.25, consensus $2.26
- 02/02/23
- Qualcomm reports Q1 adjusted EPS $2.37, consensus $2.34
- 11/02/22
- Qualcomm sees Q1 adjusted EPS adjusted EPS $2.25-$2.45, consensus $3.42
- 12/20/22
- Nike sees FY23 revenue growth in mid teens, consensus $49.01B
- 12/20/22
- Nike reports Q2 EPS 85c, consensus 65c
- 12/20/22
- Notable companies reporting after market close
- 09/29/22
- Nike reports Q1 EPS 93c, consensus 92c
- 01/09/23
- Lululemon narrows Q4 adjusted EPS view to $4.22-$4.27 from $4.20-$4.30
- 12/08/22
- Lululemon sees FY22 EPS $9.87-$9.97, consensus $9.92
- 12/08/22
- Lululemon sees Q4 EPS $4.20-$4.30, consensus $4.30
- 12/08/22
- Lululemon reports Q3 EPS $2.00, consensus $1.97
- 03/15/23
- LivePerson sees FY23 revenue $395M-$410M, consensus $551.48M
- 03/15/23
- LivePerson sees Q1 EPS $106M-$109M, consensus $132.18M
- 03/15/23
- LivePerson reports Q4 EPS (55c), consensus (35c)
- 11/07/22
- LivePerson raises FY22 revenue view to $517M-$521M from $507.1M-$518.3M
- 03/02/23
- Samsara sees FY24 EPS (7c) to (5c), consensus (15c)
- 03/02/23
- Samsara sees Q1 EPS (6c) to (5c), consensus (5c)
- 03/02/23
- Samsara reports Q4 EPS (2c), consensus (5c)
- 12/01/22
- Samsara raises FY23 EPS view to (17c)-(16c) from (23c)-(21c), consensus (21c)
- 02/23/23
- Intuit reports Q2 EPS $2.20, consensus $1.44
- 02/23/23
- Notable companies reporting after market close
- 11/29/22
- Intuit sees Q2 adjusted EPS $1.41-$1.45, consensus $2.06
- 11/29/22
- Intuit backs FY23 adjusted EPS view $13.59-$13.89, consensus $13.75
- 02/22/23
- Intel backs Q1 EPS view (15c), consensus (15c)
- 02/16/23
- Tower Semiconductor not providing Q1 revenue guidance
- 01/26/23
- Intel sees Q1 EPS (15c), consensus 24c
- 01/26/23
- Intel reports Q4 EPS 10c, consensus 20c
- 03/15/23
- Halozyme reaffirms FY23 revenue view $815M-$845M, consensus $829.01M
- 02/21/23
- Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.78
- 02/21/23
- Halozyme reports Q4 adjusted EPS 48c, consensus 47c
- 01/10/23
- Halozyme sees FY23 adjusted EPS $2.50-$2.65, consensus $2.90
- 12/20/22
- FedEx sees FY23 EPS before-MTM ex-costs $13-$14, consensus $14.08
- 12/20/22
- FedEx reports Q2 adjusted EPS $3.18, consensus $2.82
- 09/22/22
- FedEx reports Q1 Express revenue $11.127B, up 1%
- 02/21/23
- Esperion reports Q4 EPS (76c), consensus (84c)
- 01/08/23
- Esperion reports preliminary Q4 revenue $14.4M-$15.1M, consensus $21.07M
- 11/01/22
- Esperion reports Q3 EPS (81c), consensus (92c)
- 01/31/23
- AMD sees Q1 revenue $5.3B +/- $300M, consensus $5.48B
- 01/31/23
- AMD reports Q4 EPS 69c, consensus 67c
- 01/31/23
- Notable companies reporting after market close
- 11/01/22
- AMD cuts FY22 revenue view to $23.5B +/- $300M from $26.3B +/- $300M
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
- 02/11/23
- Toast more than just restaurant payments, stock looks like a buy, Barron's says
- 11/28/22
- Crypto lender BlockFi files for bankruptcy amid FTX 'entanglement,' NYT says
- 03/10/23
- U.S. to further tighten chip gear export to China restrictions, Bloomberg says
- 03/10/23
- U.S. to further tighten chip gear export to China restrictions, Bloomberg says
- 03/02/23
- Qualcomm to remain sole iPhone modem chip supplier in 2023, DigiTimes reports
- 02/13/23
- Democrats want tighter limit on stock buybacks in chip subsidies, Bloomberg says
- 12/05/22
- Nike cut ties with Kyrie Irving, The Athletic reports
- 11/25/22
- Brookfield acquired Nike label supplier Trimco Group, Bloomberg reports
- 11/15/22
- Nike to open online store for virtual sneakers, Bloomberg reports
- 10/15/22
- Shortages have turned to gluts, off-price retailers could benefit, Barron's says
- 09/30/22
- Peloton tells Bloomberg resolved dispute with Lululemon over athletic wear
- 09/29/22
- Peloton suit against Lululemon thrown out by court, Bloomberg reports
- 09/29/22
- Lululemon wins dismissal of patent suit by Peloton, Bloomberg reports
- 01/18/23
- Intuit admits to MailChimp data breach, NY Post reports
- 11/03/22
- Short seller Bear Cave sees Intuit suffering after 'predatory behavior'
- 11/01/22
- Intuit pauses hiring at Credit Karma unit amid revenue challenges, Bloomberg says
- 03/07/23
- Intel seeks extra EUR4B-EUR5B in subsidies for German chip plant, Bloomberg says
- 03/01/23
- Microsoft, Intel hint at Windows 12, The Verge reports
- 02/07/23
- Southwest, FedEx planes may have come within 100 feet of each other, WSJ reports
- 02/01/23
- FedEx cutting management positions by over 10%, Bloomberg reports
- 02/01/23
- FedEx cutting management positions by over 10%, Bloomberg reports
- 01/10/23
- FedEx reduces Sunday deliveries 'again' amid e-commerce decline, Bloomberg says
- 03/02/23
- Third Point's Loeb took passive AMD stake amid selloff, CNBC reports
- 03/02/23
- Dan Loeb's Third Point takes passive stake in AMD, CNBC reports
- 03/16/23
- Foxconn to make AirPods for first time, Reuters reports
- 03/15/23
- Spotify's Soderstrom says HiFi still 'coming at some point,' The Verge reports
- 03/14/23
- Apple delaying some bonuses, expanding hiring freeze, Bloomberg says
- 03/14/23
- Apple delaying some bonuses, expanding hiring freeze, Bloomberg says
- 03/13/23
- What You Missed On Wall Street On Monday
- 03/13/23
- What You Missed On Wall Street This Morning
- 03/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/06/23
- Fly Intel: After-Hours Movers
- 01/23/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 11/30/22
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/24/23
- What You Missed On Wall Street On Friday
- 02/24/23
- What You Missed On Wall Street This Morning
- 02/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/02/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/13/23
- What You Missed On Wall Street On Monday
- 02/03/23
- What You Missed On Wall Street On Friday
- 02/11/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 02/07/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/01/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/28/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/24/23
- What You Missed On Wall Street On Tuesday
- 01/24/23
- What You Missed On Wall Street This Morning
- 03/16/23
- Fly Intel: Pre-market Movers
- 03/15/23
- Fly Intel: After-Hours Movers
- 03/16/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/03/23
- What You Missed On Wall Street On Friday
- 03/03/23
- What You Missed On Wall Street This Morning
- 02/15/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/23/23
- Fly Intel: After-Hours Movers
- 01/18/23
- What You Missed On Wall Street On Wednesday
- 01/18/23
- What You Missed On Wall Street This Morning
- 03/08/23
- What You Missed On Wall Street This Morning
- 03/01/23
- What You Missed On Wall Street On Wednesday
- 03/15/23
- Fly Intel: Pre-market Movers
- 01/11/23
- What You Missed On Wall Street On Wednesday
- 01/11/23
- What You Missed On Wall Street This Morning
- 02/02/23
- What You Missed On Wall Street On Thursday
- 02/02/23
- What You Missed On Wall Street This Morning
- 02/02/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/07/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 03/06/23
- What You Missed On Wall Street On Monday
- 03/06/23
- What You Missed On Wall Street This Morning
- 03/10/23
- Here's What You Missed in Crypto This Week
- 03/04/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 03/03/23
- Here's What You Missed in Crypto This Week
- 03/14/23
- What You Missed On Wall Street On Tuesday
- 03/14/23
- What You Missed On Wall Street This Morning
- 10/31/22
- Under Armour Class A call volume above normal and directionally bullish
- 10/10/22
- Under Armour Class A call volume above normal and directionally bullish
- 02/07/23
- Early notable gainers among liquid option names on February 7th
- 02/06/23
- Skyworks options imply 4.9% move in share price post-earnings
- 12/28/22
- Skyworks put volume heavy and directionally bearish
- 12/15/22
- Skyworks put volume heavy and directionally bearish
- 02/23/23
- Square options imply 7.8% move in share price post-earnings
- 01/23/23
- Unusually active option classes on open January 23rd
- 01/19/23
- Square put volume heavy and directionally bearish
- 11/03/22
- Square options imply 10.4% move in share price post-earnings
- 02/02/23
- Qualcomm options imply 4.6% move in share price post-earnings
- 01/30/23
- Largest borrow rate increases among liquid names
- 01/23/23
- Early notable gainers among liquid option names on January 23rd
- 12/22/22
- Unusually active option classes on open December 22nd
- 12/21/22
- Early notable gainers among liquid option names on December 21st
- 12/21/22
- Notable open interest changes for December 21st
- 12/20/22
- Nike options imply 7.5% move in share price post-earnings
- 01/24/23
- Unusually active option classes on open January 24th
- 01/04/23
- Lululemon put volume heavy and directionally bearish
- 12/21/22
- Unusually active option classes on open December 21st
- 12/12/22
- Unusually active option classes on open December 12th
- 03/15/23
- LivePerson options imply 13.3% move in share price post-earnings
- 12/01/22
- Samsara options imply 14.8% move in share price post-earnings
- 02/24/23
- Early notable gainers among liquid option names on February 24th
- 11/29/22
- Intuit options imply 5.6% move in share price post-earnings
- 11/01/22
- Intuit put volume heavy and directionally bearish
- 09/16/22
- Intuit call volume above normal and directionally bullish
- 03/16/23
- Unusually active option classes on open March 16th
- 01/30/23
- Notable open interest changes for January 30th
- 01/27/23
- Notable open interest changes for January 27th
- 12/23/22
- Unusually active option classes on open December 23rd
- 12/22/22
- Early notable gainers among liquid option names on December 22nd
- 12/15/22
- Fedex put volume heavy and directionally bearish
- 01/06/23
- Esperion call volume above normal and directionally bullish
- 12/19/22
- Esperion put volume heavy and directionally bearish
- 12/07/22
- Unusually active option classes on open December 7th
- 11/17/22
- Largest borrow rate increases among liquid names
- 03/16/23
- Early notable gainers among liquid option names on March 16th
- 02/23/23
- Unusually active option classes on open February 23rd
- 02/02/23
- Notable open interest changes for February 2nd
- 02/01/23
- Early notable gainers among liquid option names on February 1st
- 03/15/23
- Notable open interest changes for March 15th
- 03/14/23
- Notable open interest changes for March 14th
- 03/09/23
- Notable open interest changes for March 9th
- 03/07/23
- Notable open interest changes for March 7th
|
Upgrade
|
Williams Trading analyst… Williams Trading analyst Sam Poser upgraded Under Armour to Buy from Hold with an $11 price target. ShowHide Related Items >><< - 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 03/16/23 Redburn
- Under Armour initiated with a Buy at Redburn
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 03/13/23
- What You Missed On Wall Street On Monday
- 03/13/23
- What You Missed On Wall Street This Morning
- 03/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/08/23
- What You Missed On Wall Street On Wednesday
- 10/31/22
- Under Armour Class A call volume above normal and directionally bullish
- 10/10/22
- Under Armour Class A call volume above normal and directionally bullish
|
Initiation
|
Redburn analyst Geoff… Redburn analyst Geoff Lowery initiated coverage of Under Armour with a Buy rating and $13.50 fair value estimate. There is limited confidence in the company's growth and margin recovery, which presents an opportunity, the analyst tells investors in a research note. Under Armour shares are near all-time relative lows, but it is making progress in footwear, international excluding Asia and wider execution, contends the firm. It says that while there is risk in the short term, there is potentially meaningful upside to consensus estimates in outer years. ShowHide Related Items >><< - 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 03/13/23
- What You Missed On Wall Street On Monday
- 03/13/23
- What You Missed On Wall Street This Morning
- 03/13/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/08/23
- What You Missed On Wall Street On Wednesday
- 10/31/22
- Under Armour Class A call volume above normal and directionally bullish
- 10/10/22
- Under Armour Class A call volume above normal and directionally bullish
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Zynex to postpone Q4 results release, call
- 02/21/23
- Zynex leases new facility in Colorado
- 02/17/23
- Zynex set to join the MSCI USA Small Cap Index
- 11/01/22
- Zynex announces $10M share repurchase program
- 03/13/23
- ZIM Integrated rises 15.9%
- 03/13/23
- ZIM Integrated rises 17.4%
- 03/13/23
- ZIM Integrated rises 12.6%
- 02/13/23
- ZIM Integrated falls -8.3%
- 02/01/23
- Lightning eMotors: Class 3 Lightning ZEV3 van is 'Buy America' certified
- 01/10/23
- Lightning eMotors produced 128 vehicles, powertrains during Q4
- 12/16/22
- Lightning eMotors receives noncompliance notification from NYSE
- 10/11/22
- Lightning eMotors produces 104 vehicles, powertrains during Q3
- 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 03/06/23
- Tesla issues recall notice for 3,470 Model Y vehicles in U.S.
- 02/27/23
- Tesla temporarily halts FSD beta software installations until recall addressed
- 02/24/23
- SEC says Elon Musk still needs lawyer to approve tweets
- 02/22/23
- Tesla to announce move to 'California Engineering Headquarters'
- 03/01/23
- T-Mobile CEO sells $5.75M in common stock
- 02/28/23
- Nokia, Qualcomm, T-Mobile achieve 5G Carrier Aggregation
- 02/24/23
- T-Mobile announces equity investment in Movius
- 02/21/23
- Amazon launches 'Integrated Private Wireless' with telco companies
- 03/13/23
- Provention Bio cancels Q4, FY22 earnings release, conference call
- 03/13/23
- Sanofi acquires Provention Bio for $25 per share or $2.9B
- 03/07/23
- Regeneron, Sanofi announces FDA acceptance for review of Dupixent sBLA
- 02/28/23
- Regeneron and Sanofi's Kevzara approved by FDA for polymyalgia rheumatica
- 03/13/23
- ContextLogic says less than 5% of cash was held at Silicon Valley Bank
- 03/13/23
- Archer says SVB receivership has no impact on business, operations
- 03/13/23
- Amesite confirms no exposure to Silicon Valley Bank SVB
- 03/13/23
- Zenvia says exposure to SVB totals less than $100,000
- $197.66 /
+25.165 (+14.59%) - 03/09/23
- Seagen, Astellas says China's NMPA accepts BLA for enfortumab vedtoin
- 02/28/23
- Seagen CFO sells $3.65M in common stock
- 03/13/23
- Nasdaq halts Signature Bank trading
- 03/13/23
- Q2 Holdings says less than $5,000 in cash held at SVB, no deposits at Signature
- 03/13/23
- Argo Blockchain says no exposure to SVB, Signature deposits available
- 03/13/23
- SuperCom reports no exposure to Silicon Valley Bank, Signature Bank
- 02/28/23
- Rivian Automotive down 6% following quarterly report
- 02/28/23
- Rivian Automotive sees 50,000 vehicles produced in 2023
- 02/14/23
- Greenlight buys Tenet, exits Intel in Q4
- 02/13/23
- Soros Fund buys Horizon Therapeutics, exits BNY Mellon in Q4
- $24.10 /
+17.395 (+259.43%) - 11/17/22
- Provention Bio trading resumes
- 11/17/22
- Provention Bio's Tzield approved by FDA for diabetes
- 03/13/23
- Pfizer to acquire Seagen for $229 per share in cash
- 03/13/23
- Pfizer to acquire Seagen for $229 per share in cash
- 03/10/23
- Pfizer announces FDA approval of ZAVZPRET
- 03/02/23
- Cue Health announces new COVID-19 awareness collaboration with Pfizer
- 02/23/23
- Nikola provides 2023 outlook
- 02/22/23
- Nikola, E.ON and Richter Group sign collaboration agreement
- 02/22/23
- Nikola selects PlusDrive for Nikola Tre BEV, hydrogen EV in U.S.
- 02/21/23
- Nikola announces additional HYLA brand refueling station in California
- 03/13/23
- NewtekOne provides update on financial holding company transition, forecasts
- 02/07/23
- Newtek Business Services raises $20M in sale of stock to Patriot Financial
- 01/06/23
- Newtek Business Services completes acquisition of National Bank of New York City
- 12/01/22
- Newtek receives approval from OCC to acquire National Bank of New York City
- 03/13/23
- Myomo intends to reduce cash burn in 2023
- 03/13/23
- Myomo preparing for DME MAC meeting on Medicare Part B payments for MyoPro
- 03/13/23
- Myomo sees FY23 product revenue growth of between 20%-30% attainable
- 03/13/23
- Myomo: Adjusted pipeline up 50% as of December 31, company reduced headcount
- 03/10/23
- Moderna expands U.S. presence, plans to hire 2,000 by end of 2023
- 02/23/23
- Moderna says $2.8B remaining under latest buyback authorization
- 02/23/23
- Moderna backs forecast of $5B in COVID-19 sales contracted for 2023 delivery
- 02/23/23
- Moderna sees FY23 CapEx at about $1.0B and R&D expense at about $4.5B
- 03/09/23
- Meta's Oversight Board upholds decision in 'Sri Lanka pharmaceuticals' case
- 03/09/23
- Meta's Oversight Board to review handling of election content in Brazil
- 03/07/23
- Senators introduce bipartisan bill to boost US ability to ban TikTok
- 03/07/23
- Meta Platforms says Facebook reached 2 billion daily active users
- 03/13/23
- Marathon Digital reports $142M cash deposits at Signature Bank
- 03/02/23
- Marathon Digital produces 683 Bitcoin in February
- 02/28/23
- Marathon Digital cancels conference call, postpones Q4, 2022 results
- $11.40 /
-4.275 (-27.27%) - 03/13/23
- KeyCorp trading resumes
- 03/13/23
- KeyCorp trading halted, volatility trading pause
- 02/01/23
- KeyCorp raises prime lending rate to 7.75%
- 01/19/23
- KeyCorp sees FY23 NII up 6%-9%, noninterest income down 1%-3%
- $131.21 /
-2.445 (-1.83%) - 03/12/23
- Fly Intel: Top five weekend stock stories
- 03/08/23
- Gemini says JPMorgan relationship 'remains intact' despite reporting
- 02/23/23
- JPMorgan CEO: Inflation 'so insidious' it could hurt growth for 10 years
- 02/23/23
- JPMorgan CEO: It's possible interest rates could hit 6%
- $226.96 /
+32.84 (+16.92%) - 03/13/23
- Illumina board recommends shareholders not support Icahn nominees
- 03/13/23
- Icahn: Nominees to bring 'badly needed dose of sanity' to Illumina's boardroom
- 03/13/23
- Icahn nominates three people to Illumina's board of directors
- 03/13/23
- Carl Icahn issues open letter to Illumina shareholders
- 03/13/23
- iCAD engages bankers to explore strategic options for Therapy business line
- 03/13/23
- iCAD CEO Stacey Stevens resigns, Dana Brown named president, CEO
- 03/01/23
- iCAD announces new real-world clinical evidence on ProFound AI
- 01/23/23
- iCAD Pressure announces CFO transition, hires SVP, US commercial sales
- 03/13/23
- HSBC acquires Silicon Valley Bank UK for GBP 1
- 02/21/23
- HSBC sees RoTE of at least 12% for 2023 onwards
- 02/21/23
- HSBC bosts 2022 dividend to 32c per share
- 02/01/23
- HSBC raises prime rate to 7.75% from 7.50%, effective February 2
- $31.19 /
-51.19 (-62.14%) - 03/13/23
- First Republic falls -61.6%
- 03/13/23
- First Republic falls -66.9%
- 03/13/23
- First Republic falls -65.1%
- 03/13/23
- First Republic trading resumes
- 03/13/23
- Crypto names jump as bitcoin rallies above $22,500
- 03/10/23
- Cathie Wood's ARK Investment bought 119.4K shares of Coinbase today
- 03/09/23
- Cathie Wood's ARK Investment bought 354K shares of Coinbase today
- 03/08/23
- Coinbase says it has no client or corporate cash at Silvergate
- 03/10/23
- Magnite's SpringServe joins Amazon Publisher Services Ad Server Certification
- 03/08/23
- Southwest taps AWS as preferred cloud provider
- 03/08/23
- AWS selected as Southwest Airlines' preferred cloud provider
- 03/08/23
- Edible Garden says Whole Foods plans to carry Pulp sustainable sauces
- 03/09/23
- Apple says Apple Music Classical releases March 28
- 03/08/23
- Apple backs new music startup Gamma
- 03/07/23
- Sonos to add support for spatial audio on Apple Music
- 02/28/23
- Globalstar spikes 10% after disclosing $252M loan from Apple
- 03/13/23 BofA
- BofA removes rating on First Republic after SVB, Signature failures
- 03/13/23 Oppenheimer
- Coinbase price target lowered to $70 from $84 at Oppenheimer
- 03/10/23 Morgan Stanley
- SVB Financial pressures 'highly idiosyncratic,' says Morgan Stanley
- 03/10/23 Compass Point
- Compass Point says Silvergate, SVB troubles could be positive for Signature Bank
- 03/13/23 Citi
- Citi cuts Bill target but says risk/reward favorable after selloff
- 03/13/23 DA Davidson
- DA Davidson upgrades Prosperity Bancshares to Buy on 'great defensive' qualities
- 03/13/23 Morgan Stanley
- Fed's new funding program a positive for Charles Schwab, says Morgan Stanley
- 03/14/23 Jefferies
- Provention Bio downgraded to Hold from Buy at Jefferies
- 02/08/23 Morgan Stanley
- Regeneron named 'Catalyst Driven Idea' at Morgan Stanley ahead of COPD data
- 01/31/23 Berenberg
- Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
- 12/21/22 Barclays
- Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
- $24.10 /
+17.395 (+259.43%) - 03/13/23 SMBC Nikko
- Provention Bio downgraded to Neutral from Outperform at SMBC Nikko
- 03/13/23 Cantor Fitzgerald
- Provention Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
- 02/15/23 H.C. Wainwright
- Provention Bio price target lowered to $16 from $18 at H.C. Wainwright
- 03/14/23 SVB Securities
- Seagen price target raised to $229 from $141 at SVB Securities
- 03/14/23 Oppenheimer
- Seagen price target raised to $229 from $210 at Oppenheimer
- 03/14/23 Barclays
- Seagen price target raised to $228 from $145 at Barclays
- 03/14/23 JMP Securities
- Seagen downgraded to Market Perform from Outperform at JMP Securities
- $197.66 /
+25.165 (+14.59%) - 02/28/23 JPMorgan
- HSBC price target raised to 650 GBp from 570 GBp at JPMorgan
- 02/24/23 RBC Capital
- HSBC price target raised to 775 GBp from 750 GBp at RBC Capital
- 02/23/23 Berenberg
- HSBC price target raised to 780 GBp from 625 GBp at Berenberg
- 02/22/23 Barclays
- HSBC price target raised to 840 GBp from 780 GBp at Barclays
- $131.21 /
-2.445 (-1.83%) - 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 02/08/23 Keefe Bruyette
- Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
- 03/13/23 Wolfe Research
- Tesla downgraded to Peer Perform from Outperform at Wolfe Research
- 03/09/23 Morgan Stanley
- Morgan Stanley questions if Tesla has 'outgrown the Cybertruck'
- 03/08/23 Citi
- Tesla comments 'very bullish' for lithium industry, says Citi
- 03/08/23 Berenberg
- Tesla downgraded to Hold from Buy at Berenberg
- $31.19 /
-51.19 (-62.14%) - 03/13/23 Compass Point
- First Republic downgraded to Neutral from Buy at Compass Point
- 03/13/23 JPMorgan
- First Republic selloff a 'dramatic overreaction,' says JPMorgan
- 03/13/23 Raymond James
- First Republic downgraded to Market Perform from Strong Buy at Raymond James
- 03/13/23 TD Cowen
- Moderna upgraded to Outperform from Market Perform at TD Cowen
- 03/07/23 TD Cowen
- Moderna sees several disease growth opportunities, says TD Cowen
- 03/01/23 RBC Capital
- Moderna initiated with an Outperform at RBC Capital
- 02/28/23 Deutsche Bank
- Moderna price target lowered to $200 from $225 at Deutsche Bank
- 03/13/23 Morgan Stanley
- Nikola initiated with an Equal Weight at Morgan Stanley
- 02/24/23 Deutsche Bank
- Nikola price target lowered to $3 from $5 at Deutsche Bank
- 02/24/23 TD Cowen
- Nikola price target lowered to $5 from $10 at Cowen
- 01/17/23 BTIG
- Nikola price target lowered to $5 from $7 at BTIG
- 02/22/23 BofA
- BofA sees 'very little topline visibility' for Coinbase despite Q4 beat
- 02/22/23 Oppenheimer
- Coinbase price target raised to $84 from $72 at Oppenheimer
- 02/22/23 Canaccord
- Coinbase price target lowered to $100 from $120 at Canaccord
- 03/14/23 Evercore ISI
- Apple premium to big tech 'justified,' could expand further, says Evercore ISI
- 03/13/23 Mizuho
- Mizuho applauds Meta Platforms efforts to drive efficiencies
- 03/09/23 Piper Sandler
- Piper says TikTok ownership change would have negligible value impact on peers
- 03/09/23 UBS
- Meta Platforms data points increase confidence in bull case, says UBS
- 03/10/23 LightShed Partners
- Apple cut to Sell at LightShed on more conservative outlook for iPhone sales
- 03/10/23 LightShed Partners
- Apple downgraded to Sell from Neutral at LightShed Partners
- 03/09/23 Benchmark
- Benchmark downgrades Trade Desk to Sell, says shares 'priced to perfection'
- 03/01/23 Lake Street
- Clean Energy price target lowered to $22 from $27 at Lake Street
- 02/23/23 DA Davidson
- Etsy price target raised to $161 from $121 at DA Davidson
- 02/16/23 MoffettNathanson
- RingCentral price target lowered to $52 from $55 at MoffettNathanson
- 03/10/23 BofA
- Rivian Automotive resumed with Buy, reduced target at BofA
- 03/09/23 Mizuho
- Rivian Automotive price target lowered to $35 from $37 at Mizuho
- 03/06/23 Evercore ISI
- Rivian Automotive price target lowered to $25 from $35 at Evercore ISI
- 03/02/23 Morgan Stanley
- Rivian Automotive price target lowered to $26 from $28 at Morgan Stanley
- 02/28/23 Roth MKM
- Smith Micro price target lowered to $5.50 from $7.50 at Roth MKM
- 02/06/23 MoffettNathanson
- T-Mobile downgraded at MoffettNathanson amid 'great deceleration'
- 02/06/23 MoffettNathanson
- T-Mobile downgraded to Market Perform from Outperform at MoffettNathanson
- 02/03/23 Citi
- T-Mobile price target raised to $176 from $174 at Citi
- 02/17/23 JPMorgan
- ZIM Integrated upgraded to Overweight from Neutral at JPMorgan
- 02/13/23 Barclays
- ZIM Integrated downgraded to Underweight from Equal Weight at Barclays
- 11/18/22 Barclays
- ZIM Integrated price target lowered to $26.50 from $63 at Barclays
- 09/20/22 Goldman Sachs
- ZIM Integrated price target lowered to $30 from $60 at Goldman Sachs
- $226.96 /
+32.84 (+16.92%) - 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 03/14/23 B. Riley
- Marathon Digital price target lowered to $6 from $8 at B. Riley
- 01/12/23 DA Davidson
- Marathon Digital price target lowered to $12 from $18 at DA Davidson
- 01/09/23 Jefferies
- Marathon Digital downgraded to Hold from Buy at Jefferies
- 11/08/22 Jefferies
- Marathon Digital price target lowered to $12.50 from $24 at Jefferies
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- $11.40 /
-4.275 (-27.27%) - 03/13/23 Odeon Capital
- KeyCorp downgraded to Hold from Buy at Odeon Capital
- 03/10/23 Piper Sandler
- KeyCorp upgraded to Neutral from Underweight at Piper Sandler
- 03/10/23 Baird
- KeyCorp upgraded to Outperform from Neutral at Baird
- 01/24/23 Alliance Global Partners
- Myomo price target lowered to $1.60 from $3.60 at Alliance Global Partners
- 11/11/22 Alliance Global Partners
- Myomo price target lowered to $3.60 from $6 at Alliance Global Partners
- 09/28/22 Alliance Global Partners
- Alliance Global Partners says CMS determination on Myomo request could come soon
- 07/08/22 Alliance Global Partners
- Myomo price target lowered to $6.70 from $10 at Alliance Global Partners
- 11/29/22 Lake Street
- Google Health partnership 'significant positive' for iCAD, says Lake Street
- 11/28/22 JMP Securities
- JMP views iCAD agreement with Google Health 'very favorably'
- 11/11/22 Lake Street
- iCAD price target lowered to $5 from $8 at Lake Street
- 09/01/22 JMP Securities
- iCAD price target lowered to $7 from $13 at JMP Securities
- 02/22/23 Piper Sandler
- NewtekOne initiated with a Neutral at Piper Sandler
- 08/08/22 Raymond James
- Newtek Business Services upgraded to Market Perform from Underperform at Raymond James
- 08/08/22 Raymond James
- Newtek Business upgraded to Market Perform from Underperform at Raymond James
- 01/17/23 Piper Sandler
- Zynex Q4 pre-announcement 'another high-watermark' quarter, says Piper Sandler
- 01/06/23 Piper Sandler
- Zynex upgraded to Overweight from Neutral at Piper Sandler
- 10/28/22 B. Riley
- Zynex price target raised to $12.50 from $11 at B. Riley
- 10/28/22 H.C. Wainwright
- Zynex price target raised to $21 from $20 at H.C. Wainwright
- 03/14/23 Northland
- Lightning eMotors price target lowered to $1.50 from $2.50 at Northland
- 03/13/23 Oppenheimer
- Opco downgrades Lightning eMotors on balance sheet uncertainty
- 03/13/23 Oppenheimer
- Lightning eMotors downgraded to Perform from Outperform at Oppenheimer
- 01/12/23 Northland
- Supplier news timing 'couldn't be worse' for Lightning eMotors, says Northland
- 03/13/23
- Zynex sees FY23 EPS 40c-50c, consensus 52c
- 03/13/23
- Zynex sees Q1 EPS 0c-3c, consensus 4c
- 03/13/23
- Zynex reports Q4 EPS 20c, consensus 19c
- 01/17/23
- Zynex still sees 2022 revenue $157.4M-$160.4M, consensus $159.08M
- 03/13/23
- ZIM Integrated reports Q4 EPS $3.44, consensus $3.05
- 11/16/22
- ZIM Integrated lowers FY22 adjusted EBITDA view to $7.4B-$7.7B from $7.8B-$8.2B
- 11/16/22
- ZIM Integrated reports Q3 EPS $9.66, consensus $9.54
- 03/13/23
- Lightning eMotors sees FY23 revenue $35M-$50M, consensus $124.04M
- 03/13/23
- Lightning eMotors reports Q4 EPS (11c), consensus (27c)
- 01/10/23
- Lightning eMotors cuts Q4 revenue view to about $4M, consensus $15.03M
- 11/07/22
- Lightning eMotors sees Q4 revenue $13M-$18M, consensus $20.76M
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 02/01/23
- T-Mobile reports Q4 EPS $1.18, consensus $1.10
- 01/31/23
- Notable companies reporting before tomorrow's open
- 01/04/23
- T-Mobile sees FY22 postpaid net customer additions 6.4M
- 02/03/23
- Sanofi sees 2023 business EPS up at low single digit rate at CER
- 02/03/23
- Sanofi reports Q4 business EPS EUR 1.71, up 17.4% at CER
- 10/28/22
- Sanofi now sees 2022 business EPS growing 16% at CER
- 10/28/22
- Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER
- 03/10/23
- Compugen considers exposure to SVB Financial as immaterial
- 01/19/23
- SVB Financial reports Q4 EPS $4.62, consensus $5.27
- 10/20/22
- SVB Financial reports Q3 EPS $7.21, consensus $6.95
- $197.66 /
+25.165 (+14.59%) - 02/15/23
- Seagen sees FY23 revenue $2.14B-$2.24B, consensus $2.3B
- 02/15/23
- Seagen reports Q4 EPS (80c), consensus ($1.04)
- 10/27/22
- Seagen raises FY22 revenue $1.82B-$1.865B from $1.71B-$1.795B
- 10/27/22
- Seagen reports Q3 EPS ($1.03), consensus (95c)
- 01/17/23
- Signature Bank reports Q4 EPS $4.65, consensus $4.89
- 10/18/22
- Signature Bank reports Q3 EPS $5.57, consensus $5.41
- 10/17/22
- Notable companies reporting before tomorrow's open
- 02/28/23
- Rivian Automotive reports Q4 adjusted EPS ($1.73), consensus ($1.94)
- 02/28/23
- Notable companies reporting after market close
- 11/09/22
- Rivian Automotive reports Q3 adjusted EPS ($1.57), consensus ($1.82)
- $24.10 /
+17.395 (+259.43%) - 11/03/22
- Provention Bio reports Q3 EPS (34c), consensus (42c)
- 01/31/23
- Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44
- 01/31/23
- Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05
- 01/30/23
- Notable companies reporting before tomorrow's open
- 02/23/23
- Nikola reports Q4 adjusted EPS (37c), consensus (43c)
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 03/13/23
- NewtekOne reiterates FY23 EPS view $1.70-$2.00, one estimate $1.64
- 03/13/23
- NewtekOne reiterates FY24 EPS view $2.80-$3.20, two estimates $2.62
- 02/27/23
- NewtekOne sees FY23 EPS $1.70-$2.00, consensus $2.13
- 02/27/23
- NewtekOne reports Q4 EPS 6c, consensus 63c
- 03/13/23
- Myomo reports Q4 EPS (29c), consensus (42c)
- 11/10/22
- Myomo reports Q3 EPS (40c), consensus (43c)
- 02/23/23
- Moderna reports Q4 EPS $3.61, consensus $4.67
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Moderna reports Q3 EPS $2.53, consensus $3.29
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 11/08/22
- Marathon Digital reports Q3 EPS (65c), consensus (35c)
- $11.40 /
-4.275 (-27.27%) - 03/06/23
- KeyCorp cuts FY23 NII growth view to 1%-4% from 6%-9%
- 01/19/23
- KeyCorp reports Q4 EPS 38c, consensus 54c
- 01/18/23
- Notable companies reporting before tomorrow's open
- $131.21 /
-2.445 (-1.83%) - 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- $226.96 /
+32.84 (+16.92%) - 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/13/23
- iCAD sees Q4 revenue $6.5M, consensus $6.61M
- 02/21/23
- HSBC reports FY22 EPS 74c vs. 62c last year
- 10/25/22
- HSBC reports Q3 EPS 10c vs. 17c last year
- $31.19 /
-51.19 (-62.14%) - 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 02/21/23
- Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y
- 02/21/23
- Notable companies reporting after market close
- 01/10/23
- Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail'
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 02/02/23
- Amazon sees Q1 revenue $121B-$126B, consensus $125.11B
- 02/02/23
- Amazon reports Q4 EPS 3c with Rivian loss, consensus 17c
- 10/27/22
- Amazon sees Q4 revenue $140B-$148B, consensus $155.15B
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/06/23
- Zynex to postpone Q4 results release, call
- 02/21/23
- Zynex leases new facility in Colorado
- 02/17/23
- Zynex set to join the MSCI USA Small Cap Index
- 11/01/22
- Zynex announces $10M share repurchase program
- 03/13/23
- ZIM Integrated rises 15.9%
- 03/13/23
- ZIM Integrated rises 17.4%
- 03/13/23
- ZIM Integrated rises 12.6%
- 02/13/23
- ZIM Integrated falls -8.3%
- 02/01/23
- Lightning eMotors: Class 3 Lightning ZEV3 van is 'Buy America' certified
- 01/10/23
- Lightning eMotors produced 128 vehicles, powertrains during Q4
- 12/16/22
- Lightning eMotors receives noncompliance notification from NYSE
- 10/11/22
- Lightning eMotors produces 104 vehicles, powertrains during Q3
- 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 03/06/23
- Tesla issues recall notice for 3,470 Model Y vehicles in U.S.
- 02/27/23
- Tesla temporarily halts FSD beta software installations until recall addressed
- 02/24/23
- SEC says Elon Musk still needs lawyer to approve tweets
- 02/22/23
- Tesla to announce move to 'California Engineering Headquarters'
- 03/13/23
- Provention Bio cancels Q4, FY22 earnings release, conference call
- 03/13/23
- Sanofi acquires Provention Bio for $25 per share or $2.9B
- 03/07/23
- Regeneron, Sanofi announces FDA acceptance for review of Dupixent sBLA
- 02/28/23
- Regeneron and Sanofi's Kevzara approved by FDA for polymyalgia rheumatica
- 03/13/23
- AvePoint says no deposits, other direct investments held at SVB
- 03/13/23
- Research Solutions evaluating accessibility to revolving credit facilities
- 03/13/23
- Inter&Co says does not have exposure to Silicon Valley Bank
- $200.65 /
+28.16 (+16.33%) - 03/09/23
- Seagen, Astellas says China's NMPA accepts BLA for enfortumab vedtoin
- 02/28/23
- Seagen CFO sells $3.65M in common stock
- 03/13/23
- SuperCom reports no exposure to Silicon Valley Bank, Signature Bank
- 03/13/23
- Sixth Street says no direct exposure to SVB, minimal impact from Signature Bank
- 03/13/23
- MAIA Biotechnology reports no exposure to Silicon Valley Bank
- 03/13/23
- Marathon Digital reports $142M cash deposits at Signature Bank
- $24.00 /
+17.29 (+257.87%) - 11/17/22
- Provention Bio trading resumes
- 11/17/22
- Provention Bio's Tzield approved by FDA for diabetes
- 03/13/23
- Pfizer to acquire Seagen for $229 per share in cash
- 03/13/23
- Pfizer to acquire Seagen for $229 per share in cash
- 03/10/23
- Pfizer announces FDA approval of ZAVZPRET
- 03/02/23
- Cue Health announces new COVID-19 awareness collaboration with Pfizer
- 02/23/23
- Nikola provides 2023 outlook
- 02/22/23
- Nikola, E.ON and Richter Group sign collaboration agreement
- 02/22/23
- Nikola selects PlusDrive for Nikola Tre BEV, hydrogen EV in U.S.
- 02/21/23
- Nikola announces additional HYLA brand refueling station in California
- 03/13/23
- NewtekOne provides update on financial holding company transition, forecasts
- 02/07/23
- Newtek Business Services raises $20M in sale of stock to Patriot Financial
- 01/06/23
- Newtek Business Services completes acquisition of National Bank of New York City
- 12/01/22
- Newtek receives approval from OCC to acquire National Bank of New York City
- 03/13/23
- Myomo intends to reduce cash burn in 2023
- 03/13/23
- Myomo preparing for DME MAC meeting on Medicare Part B payments for MyoPro
- 03/13/23
- Myomo sees FY23 product revenue growth of between 20%-30% attainable
- 03/13/23
- Myomo: Adjusted pipeline up 50% as of December 31, company reduced headcount
- 03/10/23
- Moderna expands U.S. presence, plans to hire 2,000 by end of 2023
- 02/23/23
- Moderna says $2.8B remaining under latest buyback authorization
- 02/23/23
- Moderna backs forecast of $5B in COVID-19 sales contracted for 2023 delivery
- 02/23/23
- Moderna sees FY23 CapEx at about $1.0B and R&D expense at about $4.5B
- 03/09/23
- Meta's Oversight Board upholds decision in 'Sri Lanka pharmaceuticals' case
- 03/09/23
- Meta's Oversight Board to review handling of election content in Brazil
- 03/07/23
- Senators introduce bipartisan bill to boost US ability to ban TikTok
- 03/07/23
- Meta Platforms says Facebook reached 2 billion daily active users
- 03/02/23
- Marathon Digital produces 683 Bitcoin in February
- 02/28/23
- Marathon Digital cancels conference call, postpones Q4, 2022 results
- $12.55 /
-3.125 (-19.94%) - 03/13/23
- KeyCorp trading resumes
- 03/13/23
- KeyCorp trading halted, volatility trading pause
- 02/01/23
- KeyCorp raises prime lending rate to 7.75%
- 01/19/23
- KeyCorp sees FY23 NII up 6%-9%, noninterest income down 1%-3%
- $131.96 /
-1.695 (-1.27%) - 03/12/23
- Fly Intel: Top five weekend stock stories
- 03/08/23
- Gemini says JPMorgan relationship 'remains intact' despite reporting
- 02/23/23
- JPMorgan CEO: Inflation 'so insidious' it could hurt growth for 10 years
- 02/23/23
- JPMorgan CEO: It's possible interest rates could hit 6%
- $234.50 /
+40.38 (+20.80%) - 03/13/23
- Icahn: Nominees to bring 'badly needed dose of sanity' to Illumina's boardroom
- 03/13/23
- Icahn nominates three people to Illumina's board of directors
- 03/13/23
- Carl Icahn issues open letter to Illumina shareholders
- 03/02/23
- Myriad Genetics, Illumina expand partnership for HRD testing access
- 03/13/23
- iCAD engages bankers to explore strategic options for Therapy business line
- 03/13/23
- iCAD CEO Stacey Stevens resigns, Dana Brown named president, CEO
- 03/01/23
- iCAD announces new real-world clinical evidence on ProFound AI
- 01/23/23
- iCAD Pressure announces CFO transition, hires SVP, US commercial sales
- 03/13/23
- Hut 8 Mining provides update on USBTC combination
- 03/10/23
- Hut 8 Mining receives no-action letter from Competition Bureau of Canada
- 03/07/23
- Hut 8 Mining mines 156 Bitcoin in February
- 02/21/23
- Hut 8 Mining provides update on North Bay facility
- 03/13/23
- HSBC acquires Silicon Valley Bank UK for GBP 1
- 02/21/23
- HSBC sees RoTE of at least 12% for 2023 onwards
- 02/21/23
- HSBC bosts 2022 dividend to 32c per share
- 02/01/23
- HSBC raises prime rate to 7.75% from 7.50%, effective February 2
- $30.69 /
-51.69 (-62.75%) - 03/13/23
- First Republic falls -61.6%
- 03/13/23
- First Republic falls -66.9%
- 03/13/23
- First Republic falls -65.1%
- 03/13/23
- First Republic trading resumes
- 03/13/23
- ConocoPhillips 'welcomes' record of decision on Willow project
- 02/27/23
- Aris Water says ExxonMobil added to water reuse agreement
- 02/23/23
- ConocoPhillips Director R.A. Walker buys $618K in company shares
- 01/22/23
- Fly Intel: Top five weekend stock stories
- 03/13/23
- Crypto names jump as bitcoin rallies above $22,500
- 03/10/23
- Cathie Wood's ARK Investment bought 119.4K shares of Coinbase today
- 03/09/23
- Cathie Wood's ARK Investment bought 354K shares of Coinbase today
- 03/08/23
- Coinbase says it has no client or corporate cash at Silvergate
- 03/09/23
- Apple says Apple Music Classical releases March 28
- 03/08/23
- Apple backs new music startup Gamma
- 03/07/23
- Sonos to add support for spatial audio on Apple Music
- 02/28/23
- Globalstar spikes 10% after disclosing $252M loan from Apple
- $131.96 /
-1.695 (-1.27%) - 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 02/08/23 Keefe Bruyette
- Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
- 03/13/23 BofA
- BofA removes rating on First Republic after SVB, Signature failures
- 03/13/23 Oppenheimer
- Coinbase price target lowered to $70 from $84 at Oppenheimer
- 03/10/23 Morgan Stanley
- SVB Financial pressures 'highly idiosyncratic,' says Morgan Stanley
- 03/10/23 Compass Point
- Compass Point says Silvergate, SVB troubles could be positive for Signature Bank
- 03/13/23 Citi
- Citi cuts Bill target but says risk/reward favorable after selloff
- 03/13/23 DA Davidson
- DA Davidson upgrades Prosperity Bancshares to Buy on 'great defensive' qualities
- 03/13/23 Morgan Stanley
- Fed's new funding program a positive for Charles Schwab, says Morgan Stanley
- 02/08/23 Morgan Stanley
- Regeneron named 'Catalyst Driven Idea' at Morgan Stanley ahead of COPD data
- 01/31/23 Berenberg
- Sanofi price target raised to EUR 100 from EUR 91 at Berenberg
- 12/21/22 Barclays
- Sanofi, Pfizer settled first California Zantac bellwether case, says Barclays
- 12/16/22 Goldman Sachs
- Sanofi reinstated with a Buy at Goldman Sachs
- $24.00 /
+17.29 (+257.87%) - 03/13/23 Cantor Fitzgerald
- Provention Bio downgraded to Neutral from Overweight at Cantor Fitzgerald
- 02/15/23 H.C. Wainwright
- Provention Bio price target lowered to $16 from $18 at H.C. Wainwright
- 11/22/22 Guggenheim
- MacroGenics upgraded to Buy at Guggenheim ahead of near-term catalysts
- 11/19/22 Chardan
- Provention Bio price target raised to $30 from $24 at Chardan
- 03/06/23 Jefferies
- Jefferies starts Pfizer with a Hold on lack of visibility
- 03/06/23 Jefferies
- Pfizer initiated with a Hold at Jefferies
- 03/03/23 SVB Securities
- SVB says Pfizer could create value for holders with Seagen bid up to $253
- 02/28/23 Oppenheimer
- Seagen price target raised to $210 from $180 at Oppenheimer
- $200.65 /
+28.16 (+16.33%) - 03/13/23 Evercore ISI
- Seagen downgraded to In Line from Outperform at Evercore ISI
- 03/06/23 Needham
- Seagen price target raised to $185 from $178 at Needham
- 03/13/23 Wolfe Research
- Tesla downgraded to Peer Perform from Outperform at Wolfe Research
- 03/09/23 Morgan Stanley
- Morgan Stanley questions if Tesla has 'outgrown the Cybertruck'
- 03/08/23 Citi
- Tesla comments 'very bullish' for lithium industry, says Citi
- 03/08/23 Berenberg
- Tesla downgraded to Hold from Buy at Berenberg
- $30.69 /
-51.69 (-62.75%) - 03/13/23 Compass Point
- First Republic downgraded to Neutral from Buy at Compass Point
- 03/13/23 JPMorgan
- First Republic selloff a 'dramatic overreaction,' says JPMorgan
- 03/13/23 Raymond James
- First Republic downgraded to Market Perform from Strong Buy at Raymond James
- 03/13/23 TD Cowen
- Moderna upgraded to Outperform from Market Perform at TD Cowen
- 03/07/23 TD Cowen
- Moderna sees several disease growth opportunities, says TD Cowen
- 03/01/23 RBC Capital
- Moderna initiated with an Outperform at RBC Capital
- 02/28/23 Deutsche Bank
- Moderna price target lowered to $200 from $225 at Deutsche Bank
- 03/13/23 Morgan Stanley
- Nikola initiated with an Equal Weight at Morgan Stanley
- 02/24/23 Deutsche Bank
- Nikola price target lowered to $3 from $5 at Deutsche Bank
- 02/24/23 TD Cowen
- Nikola price target lowered to $5 from $10 at Cowen
- 01/17/23 BTIG
- Nikola price target lowered to $5 from $7 at BTIG
- $234.50 /
+40.38 (+20.80%) - 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 02/08/23 Stifel
- Illumina price target lowered to $235 from $285 at Stifel
- 02/08/23 RBC Capital
- Illumina price target raised to $303 from $284 at RBC Capital
- 02/22/23 BofA
- BofA sees 'very little topline visibility' for Coinbase despite Q4 beat
- 02/22/23 Oppenheimer
- Coinbase price target raised to $84 from $72 at Oppenheimer
- 02/22/23 Canaccord
- Coinbase price target lowered to $100 from $120 at Canaccord
- 03/10/23 Mizuho
- ConocoPhillips price target lowered to $143 from $150 at Mizuho
- 02/27/23 Citi
- ConocoPhillips price target lowered to $145 from $160 at Citi
- 02/03/23 Capital One
- ConocoPhillips downgraded to Equalweight from Overweight at Capital One
- 01/26/23 Goldman Sachs
- Hess Corp. downgraded to Neutral from Buy at Goldman Sachs
- 03/13/23 Mizuho
- Mizuho applauds Meta Platforms efforts to drive efficiencies
- 03/09/23 Piper Sandler
- Piper says TikTok ownership change would have negligible value impact on peers
- 03/09/23 UBS
- Meta Platforms data points increase confidence in bull case, says UBS
- 03/09/23 Oppenheimer
- Meta Platforms price target raised to $235 from $220 at Oppenheimer
- 03/10/23 LightShed Partners
- Apple cut to Sell at LightShed on more conservative outlook for iPhone sales
- 03/10/23 LightShed Partners
- Apple downgraded to Sell from Neutral at LightShed Partners
- 03/09/23 Benchmark
- Benchmark downgrades Trade Desk to Sell, says shares 'priced to perfection'
- 03/08/23 Wedbush
- Apple price target raised to $190 from $180 at Wedbush
- 02/17/23 JPMorgan
- ZIM Integrated upgraded to Overweight from Neutral at JPMorgan
- 02/13/23 Barclays
- ZIM Integrated downgraded to Underweight from Equal Weight at Barclays
- 11/18/22 Barclays
- ZIM Integrated price target lowered to $26.50 from $63 at Barclays
- 09/20/22 Goldman Sachs
- ZIM Integrated price target lowered to $30 from $60 at Goldman Sachs
- 03/13/23 Canaccord
- Hut 8 Mining price target lowered to $5.00 from $6.00 at Canaccord
- 12/09/22 H.C. Wainwright
- Hut 8 Mining assumed with a Neutral at H.C. Wainwright
- 11/11/22 Craig-Hallum
- Hut 8 Mining downgraded to Hold from Buy at Craig-Hallum
- 11/11/22 Craig-Hallum
- Hut 8 Mining downgraded to Hold from Buy at Craig-Hallum
- 01/12/23 DA Davidson
- Marathon Digital price target lowered to $12 from $18 at DA Davidson
- 01/09/23 Jefferies
- Marathon Digital downgraded to Hold from Buy at Jefferies
- 11/08/22 Jefferies
- Marathon Digital price target lowered to $12.50 from $24 at Jefferies
- 10/25/22 Compass Point
- Marathon Digital price target lowered to $21 from $30 at Compass Point
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- $12.55 /
-3.125 (-19.94%) - 03/13/23 Odeon Capital
- KeyCorp downgraded to Hold from Buy at Odeon Capital
- 03/10/23 Piper Sandler
- KeyCorp upgraded to Neutral from Underweight at Piper Sandler
- 03/10/23 Baird
- KeyCorp upgraded to Outperform from Neutral at Baird
- 01/24/23 Alliance Global Partners
- Myomo price target lowered to $1.60 from $3.60 at Alliance Global Partners
- 11/11/22 Alliance Global Partners
- Myomo price target lowered to $3.60 from $6 at Alliance Global Partners
- 09/28/22 Alliance Global Partners
- Alliance Global Partners says CMS determination on Myomo request could come soon
- 07/08/22 Alliance Global Partners
- Myomo price target lowered to $6.70 from $10 at Alliance Global Partners
- 11/29/22 Lake Street
- Google Health partnership 'significant positive' for iCAD, says Lake Street
- 11/28/22 JMP Securities
- JMP views iCAD agreement with Google Health 'very favorably'
- 11/11/22 Lake Street
- iCAD price target lowered to $5 from $8 at Lake Street
- 09/01/22 JMP Securities
- iCAD price target lowered to $7 from $13 at JMP Securities
- 02/22/23 Piper Sandler
- NewtekOne initiated with a Neutral at Piper Sandler
- 08/08/22 Raymond James
- Newtek Business Services upgraded to Market Perform from Underperform at Raymond James
- 08/08/22 Raymond James
- Newtek Business upgraded to Market Perform from Underperform at Raymond James
- 01/17/23 Piper Sandler
- Zynex Q4 pre-announcement 'another high-watermark' quarter, says Piper Sandler
- 01/06/23 Piper Sandler
- Zynex upgraded to Overweight from Neutral at Piper Sandler
- 10/28/22 B. Riley
- Zynex price target raised to $12.50 from $11 at B. Riley
- 10/28/22 H.C. Wainwright
- Zynex price target raised to $21 from $20 at H.C. Wainwright
- 01/12/23 Northland
- Supplier news timing 'couldn't be worse' for Lightning eMotors, says Northland
- 12/05/22 Northland
- Lightning eMotors price target lowered to $2.50 from $6.50 at Northland
- 11/08/22 DA Davidson
- Lightning eMotors price target lowered to $4 from $10 at DA Davidson
- 08/31/22 Northland
- Long only investor support makes 'bold statement' on Lightning, says Northland
- 02/28/23 JPMorgan
- HSBC price target raised to 650 GBp from 570 GBp at JPMorgan
- 02/24/23 RBC Capital
- HSBC price target raised to 775 GBp from 750 GBp at RBC Capital
- 02/23/23 Berenberg
- HSBC price target raised to 780 GBp from 625 GBp at Berenberg
- 02/22/23 Barclays
- HSBC price target raised to 840 GBp from 780 GBp at Barclays
- 03/13/23
- Zynex sees FY23 EPS 40c-50c, consensus 52c
- 03/13/23
- Zynex sees Q1 EPS 0c-3c, consensus 4c
- 03/13/23
- Zynex reports Q4 EPS 20c, consensus 19c
- 01/17/23
- Zynex still sees 2022 revenue $157.4M-$160.4M, consensus $159.08M
- 03/13/23
- ZIM Integrated reports Q4 EPS $3.44, consensus $3.05
- 11/16/22
- ZIM Integrated lowers FY22 adjusted EBITDA view to $7.4B-$7.7B from $7.8B-$8.2B
- 11/16/22
- ZIM Integrated reports Q3 EPS $9.66, consensus $9.54
- 03/13/23
- Lightning eMotors sees FY23 revenue $35M-$50M, consensus $124.04M
- 03/13/23
- Lightning eMotors reports Q4 EPS (11c), consensus (27c)
- 01/10/23
- Lightning eMotors cuts Q4 revenue view to about $4M, consensus $15.03M
- 11/07/22
- Lightning eMotors sees Q4 revenue $13M-$18M, consensus $20.76M
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 02/03/23
- Sanofi sees 2023 business EPS up at low single digit rate at CER
- 02/03/23
- Sanofi reports Q4 business EPS EUR 1.71, up 17.4% at CER
- 10/28/22
- Sanofi now sees 2022 business EPS growing 16% at CER
- 10/28/22
- Sanofi reports Q3 business EPS EUR 2.88, up 17.9% at CER
- 03/10/23
- Compugen considers exposure to SVB Financial as immaterial
- 01/19/23
- SVB Financial reports Q4 EPS $4.62, consensus $5.27
- 10/20/22
- SVB Financial reports Q3 EPS $7.21, consensus $6.95
- $200.65 /
+28.16 (+16.33%) - 02/15/23
- Seagen sees FY23 revenue $2.14B-$2.24B, consensus $2.3B
- 02/15/23
- Seagen reports Q4 EPS (80c), consensus ($1.04)
- 10/27/22
- Seagen raises FY22 revenue $1.82B-$1.865B from $1.71B-$1.795B
- 10/27/22
- Seagen reports Q3 EPS ($1.03), consensus (95c)
- 01/17/23
- Signature Bank reports Q4 EPS $4.65, consensus $4.89
- 10/18/22
- Signature Bank reports Q3 EPS $5.57, consensus $5.41
- 10/17/22
- Notable companies reporting before tomorrow's open
- $24.00 /
+17.29 (+257.87%) - 11/03/22
- Provention Bio reports Q3 EPS (34c), consensus (42c)
- 01/31/23
- Pfizer sees FY23 adjusted EPS $3.25-$3.45, consensus $4.44
- 01/31/23
- Pfizer reports Q4 adjusted EPS $1.14, consensus $1.05
- 01/30/23
- Notable companies reporting before tomorrow's open
- 02/23/23
- Nikola reports Q4 adjusted EPS (37c), consensus (43c)
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 03/13/23
- NewtekOne reiterates FY23 EPS view $1.70-$2.00, one estimate $1.64
- 03/13/23
- NewtekOne reiterates FY24 EPS view $2.80-$3.20, two estimates $2.62
- 02/27/23
- NewtekOne sees FY23 EPS $1.70-$2.00, consensus $2.13
- 02/27/23
- NewtekOne reports Q4 EPS 6c, consensus 63c
- 03/13/23
- Myomo reports Q4 EPS (29c), consensus (42c)
- 11/10/22
- Myomo reports Q3 EPS (40c), consensus (43c)
- 02/23/23
- Moderna reports Q4 EPS $3.61, consensus $4.67
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Moderna reports Q3 EPS $2.53, consensus $3.29
- 02/01/23
- Meta Platforms sees Q1 revenue $26B-$28.5B, consensus $27.14B
- 02/01/23
- Meta Platforms reports Q4 EPS $1.76, consensus $2.22
- 02/01/23
- Notable companies reporting after market close
- 11/09/22
- Meta Platforms backs Q4 revenue outlook $30B-$32.5B, consensus $31.52B
- 11/08/22
- Marathon Digital reports Q3 EPS (65c), consensus (35c)
- $12.55 /
-3.125 (-19.94%) - 03/06/23
- KeyCorp cuts FY23 NII growth view to 1%-4% from 6%-9%
- 01/19/23
- KeyCorp reports Q4 EPS 38c, consensus 54c
- 01/18/23
- Notable companies reporting before tomorrow's open
- $131.96 /
-1.695 (-1.27%) - 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- $234.50 /
+40.38 (+20.80%) - 02/07/23
- Illumina sees FY23 adjusted EPS $1.25-$1.50, consensus $1.98
- 02/07/23
- Illumina reports Q4 adjusted EPS 14c, consensus 10c
- 02/07/23
- Notable companies reporting after market close
- 11/03/22
- Illumina sees FY22 adjusted EPS $2.35-$2.50, consensus $2.78
- 03/13/23
- iCAD sees Q4 revenue $6.5M, consensus $6.61M
- 02/21/23
- HSBC reports FY22 EPS 74c vs. 62c last year
- 10/25/22
- HSBC reports Q3 EPS 10c vs. 17c last year
- $30.69 /
-51.69 (-62.75%) - 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 10/14/22
- First Republic reports Q3 EPS $2.21, consensus $2.18
- 02/02/23
- ConocoPhillips reports Q4 EPS $2.71, consensus $2.81
- 11/03/22
- ConocoPhillips reports Q3 EPS $3.60, consensus $3.44
- 11/02/22
- Notable companies reporting before tomorrow's open
- 02/21/23
- Coinbase reports Q4 EPS ($2.46) vs. $3.32 y/y
- 02/21/23
- Notable companies reporting after market close
- 01/10/23
- Coinbase sees FY22 adjusted EBITDA within negative $500M loss 'guardrail'
- 12/07/22
- Coinbase CEO tells Bloomberg 2022 revenue seen down 50% or more
- 02/02/23
- Apple reports Q1 EPS $1.88, consensus $1.94
- 02/02/23
- Notable companies reporting after market close
- 10/27/22
- Apple reports Q4 EPS $1.29, consensus $1.17
- 10/27/22
- Notable companies reporting after market close
|
On The Fly
|
Want to get stock-moving… ShowHide Related Items >><< - 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 03/06/23
- Tesla issues recall notice for 3,470 Model Y vehicles in U.S.
- 02/27/23
- Tesla temporarily halts FSD beta software installations until recall addressed
- 02/24/23
- SEC says Elon Musk still needs lawyer to approve tweets
- 02/22/23
- Tesla to announce move to 'California Engineering Headquarters'
- 03/13/23
- Fisker says no cash deposits, securities at SVB Financial
- 03/13/23
- Marathon Digital reports $142M cash deposits at Signature Bank
- 03/13/23
- MAIA Biotechnology reports no exposure to Silicon Valley Bank
- 03/13/23
- BTCS reports amount equal to FDIC-insured limit of $250K at Signature Bank
- 03/13/23
- NewtekOne provides update on financial holding company transition, forecasts
- 03/13/23
- Iris Energy confirms no deposits with SVB, Signature Bank or Silvergate Capital
- 02/01/23
- PNC Financial raises prime lending rate to 7.75%, effective February 2
- 01/27/23
- Atlantic Union Bankshares names Matt Linderman as chief information officer
- 01/18/23
- PNC Financial expects to continue share repurchases at 'reduced rate' vs. 2022
- 01/18/23
- PNC Financial says well capitalized with flexibility
- 01/17/23
- Prosperity Bancshares announces roughly 4.6M share buyback
- 10/19/22
- Prosperity Bancshares increases quarterly dividend 5.77% to 55c per share
- 10/11/22
- Prosperity Bancshares to acquire First Bancshares of Texas
- 10/11/22
- Prosperity Bancshares to acquire Lone Star State Bancshares
- 01/24/23
- Orion Engineered invests $60M to reduce emissions, upgrade cogeneration system
- 11/04/22
- Orion Engineered rises 15.9%
- 11/04/22
- Orion Engineered announces $50M share repurchase program
- 03/08/23
- Nuvei sees 20%+ annual y-o-y revenue growth in medium-term
- 02/22/23
- Nuvei expects total volume, revenue, adjusted EBITDA to be in line with outlook
- 02/22/23
- Nuvei completes $1.3B acquisition of Paya Holdings
- 02/13/23
- Nuvei, Mercedes-AMG PETRONAS Formula One Team enter partnership
- 02/23/23
- Nikola provides 2023 outlook
- 02/22/23
- Nikola, E.ON and Richter Group sign collaboration agreement
- 02/22/23
- Nikola selects PlusDrive for Nikola Tre BEV, hydrogen EV in U.S.
- 02/21/23
- Nikola announces additional HYLA brand refueling station in California
- 03/10/23
- Merck says Phase 2/3 CCTG IND.227/KEYNOTE-483 trial met primary endpoint
- 03/08/23
- Opko Health enters exclusive worldwide license agreement with Merck
- 03/06/23
- Merck says MK-0616 'significantly reduced' LDL-C in Phase 2b study
- 03/06/23
- Merck: FDA approves IM route of administration for MMRV family of vaccines
- 02/21/23
- Lam Research announces new executive appointments
- 01/25/23
- Lam Research announces restructuring, 7% workforce reduction
- 12/11/22
- Fly Intel: Top five weekend stock stories
- 11/16/22
- Wafer Fab Equipment names slide after Micron cuts wafer starts
- $327.00 /
+12.055 (+3.83%) - 03/08/23
- Eli Lilly says primary, secondary endpoints not met in A4 Study
- 03/08/23
- Eli Lilly: FDA accepts sNDA for Jardiance for children 10 years and older
- 03/03/23
- Eli Lilly says FDA broadens indication for Verzenio
- 03/01/23
- Eli Lilly cuts insulin prices by 70%, caps out of pocket costs
- $132.32 /
-1.335 (-1.00%) - 03/08/23
- Gemini says JPMorgan relationship 'remains intact' despite reporting
- 02/23/23
- JPMorgan CEO: Inflation 'so insidious' it could hurt growth for 10 years
- 02/23/23
- JPMorgan CEO: It's possible interest rates could hit 6%
- 03/12/23
- Fly Intel: Top five weekend stock stories
- 03/02/23
- GE HealthCare, Advantus Health in pact to provide HTM services
- 03/01/23
- GE HealthCare completes recruitment in manganese-based MRI contrast agent study
- 02/09/23
- GE HealthCare to acquire Caption Health, terms undisclosed
- 03/06/23
- Cabot to establish new technology center in Munster
- 03/01/23
- Amgen to present new Repatha combined data from Phase 3 FOURIER trials
- 02/02/23
- Amgen's Tezspire approved in U.S. for self-administration in severe asthma
- 01/31/23
- Amgen, Horizon Therapeutics receive second request for additional info from FTC
- 01/31/23
- Amgen sees FY23 CapEx about $925M
- $126.90 /
-1.165 (-0.91%) - 02/28/23
- Advance Auto Parts says Greco to retire as president and CEO at year-end
- 11/16/22
- Advance Auto Parts falls -17.0%
- 11/16/22
- Advance Auto Parts falls -14.6%
- 11/15/22
- Advance Auto Parts falls 10% after Q3 results miss estimates, FY22 EPS view cut
- 03/13/23 Wolfe Research
- Tesla downgraded to Peer Perform from Outperform at Wolfe Research
- 03/09/23 Morgan Stanley
- Morgan Stanley questions if Tesla has 'outgrown the Cybertruck'
- 03/08/23 Citi
- Tesla comments 'very bullish' for lithium industry, says Citi
- 03/08/23 Berenberg
- Tesla downgraded to Hold from Buy at Berenberg
- 03/13/23 JPMorgan
- Nuvei reinstated with an Overweight at JPMorgan
- 03/09/23 CIBC
- Nuvei upgraded to Outperformer at CIBC following better than expected outlook
- 03/09/23 CIBC
- Nuvei upgraded to Outperformer from Neutral at CIBC
- 03/09/23 Raymond James
- Nuvei price target raised to $49 from $40 at Raymond James
- 03/13/23 Credit Suisse
- Orion Engineered initiated with an Outperform at Credit Suisse
- 03/13/23 Credit Suisse
- Cabot initiated with an Outperform at Credit Suisse
- 02/13/23 Loop Capital
- Cabot price target raised to $113 from $98 at Loop Capital
- 02/13/23 JPMorgan
- Cabot price target raised to $87 from $80 at JPMorgan
- 11/16/22 Deutsche Bank
- Cabot upgraded to Buy from Hold at Deutsche Bank
- 03/13/23 Evercore ISI
- GE HealthCare initiated with an Outperform at Evercore ISI
- 03/06/23 BofA
- General Electric price target raised to $96 at BofA ahead of investor day
- 02/17/23 Mizuho
- GE HealthCare initiated with a Buy at Mizuho
- 01/25/23 BofA
- General Electric price target raised to $92 from $85 at BofA
- 03/13/23 Morgan Stanley
- Nikola initiated with an Equal Weight at Morgan Stanley
- 02/24/23 Deutsche Bank
- Nikola price target lowered to $3 from $5 at Deutsche Bank
- 02/24/23 TD Cowen
- Nikola price target lowered to $5 from $10 at Cowen
- 01/17/23 BTIG
- Nikola price target lowered to $5 from $7 at BTIG
- 03/13/23 DA Davidson
- DA Davidson upgrades Prosperity Bancshares to Buy on 'great defensive' qualities
- 03/13/23 Morgan Stanley
- Fed's new funding program a positive for Charles Schwab, says Morgan Stanley
- 03/13/23 BofA
- Charles Schwab price target lowered to $60 from $74 at BofA
- 03/13/23 Oppenheimer
- Coinbase price target lowered to $70 from $84 at Oppenheimer
- 03/13/23 Citi
- Citi cuts Bill target but says risk/reward favorable after selloff
- 03/13/23 BofA
- BofA removes rating on First Republic after SVB, Signature failures
- 03/13/23 JPMorgan
- Under Armour downgraded to Neutral from Overweight at JPMorgan
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- $126.90 /
-1.165 (-0.91%) - 03/13/23 Argus
- Advance Auto Parts cut to Hold at Argus on flat margins, paused buybacks
- 03/13/23 Argus
- Advance Auto Parts downgraded to Hold from Buy at Argus
- 03/01/23 DA Davidson
- Advance Auto Parts price target lowered to $142 from $170 at DA Davidson
- 03/01/23 Raymond James
- Advance Auto Parts price target lowered to $180 from $200 at Raymond James
- 03/13/23 Bernstein
- Lam Research downgraded to Market Perform from Outperform at Bernstein
- 03/09/23 Citi
- Citi says HDD storage prices ticking up
- 03/01/23 KGI Securities
- Lam Research upgraded to Outperform from Neutral at KGI Securities
- 01/31/23 Citi
- Citi opens 'positive catalyst watch' on Lam Research
- 03/13/23 Wells Fargo
- Merck downgraded at Wells Fargo on valuation, lack of catalysts
- 03/13/23 Wells Fargo
- Merck downgraded to Equal Weight from Overweight at Wells Fargo
- 03/10/23 Berenberg
- Merck price target raised to $130 from $125 at Berenberg
- 03/09/23 Guggenheim
- Merck price target raised to $123 from $116 at Guggenheim
- 03/13/23 DA Davidson
- Prosperity Bancshares upgraded to Buy from Neutral at DA Davidson
- 03/13/23 Janney Montgomery Scott
- Prosperity Bancshares upgraded to Buy from Neutral at Janney Montgomery Scott
- 03/10/23 Morgan Stanley
- SVB Financial pressures 'highly idiosyncratic,' says Morgan Stanley
- 03/13/23 Citi
- PNC Financial upgraded to Buy from Neutral at Citi
- 02/15/23 Piper Sandler
- PNC Financial price target raised to $164 from $150 at Piper Sandler
- 01/19/23 Baird
- PNC Financial price target lowered to $205 from $210 at Baird
- 01/19/23 Credit Suisse
- PNC Financial price target lowered to $165 from $170 at Credit Suisse
- 03/13/23 Wells Fargo
- Wells Fargo upgrades Amgen to Overweight, lowers target to $265
- 03/13/23 Wells Fargo
- Amgen upgraded to Overweight from Equal Weight at Wells Fargo
- 02/13/23 Truist
- Amgen price target lowered to $260 from $280 at Truist
- 02/06/23 Argus
- Amgen price target lowered to $270 from $300 at Argus
- $327.00 /
+12.055 (+3.83%) - 03/13/23 Wells Fargo
- Eli Lilly upgraded to Overweight on recent selloff at Wells Fargo
- 03/13/23 Wells Fargo
- Eli Lilly upgraded to Overweight from Equal Weight at Wells Fargo
- 03/09/23 JPMorgan
- Eli Lilly weakness brings attractive entry point, says JPMorgan
- 03/06/23 Jefferies
- Jefferies starts 'priced to perfection' Eli Lilly with a Hold
- $132.32 /
-1.335 (-1.00%) - 03/13/23 Wells Fargo
- Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
- 03/13/23 Wells Fargo
- JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
- 02/24/23 Morgan Stanley
- JPMorgan price target raised to $173 from $167 at Morgan Stanley
- 02/08/23 Keefe Bruyette
- Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Aehr Test Systems reiterates annual guidance, comments on Tesla statements
- 01/25/23
- Tesla reports Q4 EPS $1.19, consensus $1.13
- 01/25/23
- Notable companies reporting after market close
- 10/19/22
- Tesla reports Q3 EPS $1.05, consensus 99c
- 03/10/23
- Compugen considers exposure to SVB Financial as immaterial
- 01/19/23
- SVB Financial reports Q4 EPS $4.62, consensus $5.27
- 10/20/22
- SVB Financial reports Q3 EPS $7.21, consensus $6.95
- 01/17/23
- Silvergate Capital reports Q4 adjusted EPS 48c, consensus 81c
- 10/18/22
- Silvergate Capital reports Q3 EPS $1.28, consensus $1.38
- 01/18/23
- PNC Financial sees FY23 revenue up 6%-8% y/y, consensus $23.28B
- 01/18/23
- PNC Financial sees Q1 revenue down about 3% vs. 4Q22, consensus $5.69B
- 01/18/23
- PNC Financial reports Q4 adjusted EPS $3.49, consensus $3.95
- 01/17/23
- Notable companies reporting before tomorrow's open
- 01/25/23
- Prosperity Bancshares reports Q4 EPS $1.51, consensus $1.49
- 10/26/22
- Prosperity Bancshares reports Q3 EPS $1.49, consensus $1.49
- 02/16/23
- Orion Engineered sees FY23 adjusted EPS $2.30-$2.60, consensus $2.55
- 02/16/23
- Orion Engineered reports Q4 adjusted EPS 23c, consensus 17c
- 11/03/22
- Orion Engineered cuts FY22 EPS view to $1.75-$1.90 from $2.00-$2.35
- 11/03/22
- Orion Engineered Carbons reports Q3 adjusted EPS 57c, consensus 56c
- 03/08/23
- Nuvei sees 2023 revenue $1.224B-$1.264B, consensus $973.4M
- 03/08/23
- Nuvei sees Q1 revenue $248M-$256M, consensus $218.97M
- 03/08/23
- Nuvei reports Q4 adjusted EPS 47c, consensus 41c
- 11/03/22
- Nuvei reaffirms FY22 revenue view $820M-$850M, consensus $837.54M
- 02/23/23
- Nikola reports Q4 adjusted EPS (37c), consensus (43c)
- 02/22/23
- Notable companies reporting before tomorrow's open
- 11/03/22
- Nikola reports Q3 adjusted EPS (28c), consensus (39c)
- 02/28/23
- NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c)
- 02/02/23
- Merck sees FY23 adjusted EPS $6.80-$6.95, consensus $7.36
- 02/02/23
- Merck reports Q4 adjusted EPS $1.62, consensus $1.54
- 02/01/23
- Notable companies reporting before tomorrow's open
- 01/25/23
- Lam Research sees March quarter adjusted EPS $6.50 +/- 75c, consensus $7.88
- 01/25/23
- Lam Research reports December quarter EPS $10.71, consensus $9.96
- 10/19/22
- Lam Research sees Q2 EPS $10.00 +/- 75c, consensus $9.47
- $327.00 /
+12.055 (+3.83%) - 03/09/23
- Precision BioSciences reports Q4 EPS (26c), consensus (21c)
- 02/02/23
- Eli Lilly raises FY23 adjusted EPS view to $8.35-$8.55 from $8.10-$8.30
- 02/02/23
- Eli Lilly reports Q4 adjusted EPS $2.09, consensus $1.78
- $132.32 /
-1.335 (-1.00%) - 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 10/14/22
- JPMorgan reports Q3 EPS $3.12, consensus $2.88
- 01/30/23
- GE HealthCare sees FY23 adjusted EPS $3.60-$3.75
- 01/30/23
- GE HealthCare reports Q4 adjusted EPS $1.31 vs. $1.36 a year ago
- 01/10/23
- GE HealthCare sees FY23 organic revenue growth 5%-7%
- 01/10/23
- GE HealthCare sees FY22 revenue about $18.3B
- 02/09/23
- Cabot sees FY23 EPS $6.25-$6.75, consensus $6.51
- 02/09/23
- Cabot reports Q1 adjusted EPS 98c, consensus 97c
- 11/07/22
- Cabot sees FY23 adjusted EPS $6.25-$6.75, consensus $6.17
- 11/07/22
- Cabot reports Q4 adjusted EPS $1.55, consensus $1.45
- 03/01/23
- Horizon Therapeutics reports Q4 EPS $1.21, consensus $1.09
- 01/31/23
- Amgen sees FY23 adjusted EPS $17.40-$18.60, consensus $18.33
- 01/31/23
- Amgen reports Q4 adjusted EPS $4.09, consensus $4.09
- 01/31/23
- Notable companies reporting after market close
- $126.90 /
-1.165 (-0.91%) - 02/28/23
- Advance Auto Parts sees FY23 EPS $10.20-$11.20
- 02/28/23
- Advance Auto Parts reports Q4 adjusted EPS $2.88, consensus $2.39
- 02/27/23
- Notable companies reporting before tomorrow's open
|
Downgrade
|
JPMorgan downgraded Under… JPMorgan downgraded Under Armour to Neutral from Overweight with a price target of $10, down from $13. The analyst expects the industry inventory overhang to persist into the summer and fall. The inventory overhang needs to be worked through, which has created a longer than expected elevated promotional environment for Under Armour, the analyst tells investors in a research note. ShowHide Related Items >><< - 02/08/23
- Under Armour expects macroeconomic backdrop to remain uneven in 2023
- 12/21/22
- Under Armour names Stephanie Linnartz as CEO
- 12/21/22
- Marriott president Stephanie Linnartz leaving to become CEO of Under Armour
- 11/18/22
- Adtalem Global Education appoints Blake Simpson as CCO
- 02/09/23 Morgan Stanley
- Under Armour price target raised to $10 from $8 at Morgan Stanley
- 02/09/23 Citi
- Under Armour price target lowered to $12 from $13 at Citi
- 02/06/23 Deutsche Bank
- Under Armour price target raised to $14 from $11 at Deutsche Bank
- 01/23/23 JPMorgan
- Under Armour price target raised to $13 from $11 at JPMorgan
- 02/08/23
- Under Armour raises FY23 adjusted EPS view to 52c-56c from 44c-48c
- 02/08/23
- Under Armour reports Q3 adjusted EPS 16c, consensus 9c
- 02/07/23
- Notable companies reporting before tomorrow's open
- 09/14/22
- Steph Curry said to be near $1B lifetime deal with Under Armour, Tribune reports
- 02/08/23
- What You Missed On Wall Street On Wednesday
- 02/08/23
- What You Missed On Wall Street This Morning
- 02/08/23
- Fly Intel: Pre-market Movers
- 12/22/22
- What You Missed On Wall Street On Thursday
- 10/31/22
- Under Armour Class A call volume above normal and directionally bullish
- 10/10/22
- Under Armour Class A call volume above normal and directionally bullish
|